We further investigated the role of the core circadian gene BMAL1 in regulating pyrimidine metabolic pathway-related genes, along with the underlying mechanism, and tested the effects of altering the expression of these genes on the sensitivity of CRC cells to 5-FU. Here, BMAL1 is linked to colorectal carcinoma.